Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?



Rating:

Share or cite this content

Citations should be made in the following way:
B. de Aguiar Mendes (Lisboa, Portugal), C. Figueiredo (Lisboa, Portugal), M. Cabral (Lisboa, Portugal), A. Borba (Lisboa, Portugal), A. Mineiro (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal), P. Calvinho (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Fragata (Lisboa, Portugal). Basiliximab vs antithymocyte globulin after lung transplantation: A national review. 2913

Member's Comments

No comment yet.

Related content which might interest you: Tacrolimus versus cyclosporine for lung transplant recipients in Portugal Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab? Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Is gammaglobuline anti-CMV warranted in lung transplantation? Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC) Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 174s Year: 2007 LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment. Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation Source: Eur Respir J 2013; 41: 479-483 Year: 2013 Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx) Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment Year: 2003 Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016 Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide Source: Eur Respir J 2004; 23: 901-905 Year: 2004 Airway cellular response to two different immunosuppressive regimens in lung transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004